Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

• Julia Boshuizen,
• David W. Vredevoogd,
• Oscar Krijgsman,
• Maarten A. Ligtenberg,
• Stephanie Blankenstein,
• Beaunelle de Bruijn,
• Dennie T. Frederick,
• Juliana C. N. Kenski,
• Mara Parren,
• Marieke Brüggemann,
• Max F. Madu,
• Elisa A. Rozeman,
• Ji-Ying Song,
• Hugo M. Horlings,
• Christian U. Blank,
• Alexander C. J. van Akkooi,
• Keith T. Flaherty,
• Genevieve M. Boland,
• Daniel S. Peeper

Affiliations

Julia Boshuizen

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

David W. Vredevoogd

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Oscar Krijgsman

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Maarten A. Ligtenberg

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Stephanie Blankenstein

Division of Surgical Oncology, The Netherlands Cancer Institute

Beaunelle de Bruijn

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Dennie T. Frederick

Department of Surgical Oncology, Massachusetts General Hospital

Juliana C. N. Kenski

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Mara Parren

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Marieke Brüggemann

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Max F. Madu

Division of Surgical Oncology, The Netherlands Cancer Institute

Elisa A. Rozeman

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Ji-Ying Song

Division of Animal Pathology, The Netherlands Cancer Institute

Hugo M. Horlings

Division of Pathology, The Netherlands Cancer Institute

Christian U. Blank

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute

Alexander C. J. van Akkooi

Division of Surgical Oncology, The Netherlands Cancer Institute

Keith T. Flaherty

Department of Medical Oncology, Massachusetts General Hospital

Genevieve M. Boland

Department of Surgical Oncology, Massachusetts General Hospital

Daniel S. Peeper

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute